Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms

被引:30
|
作者
Huang, Anna S. [1 ]
Rogers, Baxter P. [2 ]
Sheffield, Julia M. [1 ]
Jalbrzikowski, Maria E. [3 ]
Anticevic, Alan [4 ]
Blackford, Jennifer Urbano [1 ,5 ]
Heckers, Stephan [1 ]
Woodward, Neil D. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA
[3] Univ Pittsburgh, Dept Psychiat, 3811 Ohara St, Pittsburgh, PA USA
[4] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[5] Dept Vet Affairs Med Ctr, Res & Dev, Nashville, TN 37212 USA
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2020年 / 177卷 / 12期
关键词
NEURON NUMBER; MATTER VOLUME; MEDIODORSAL; PULVINAR; SCHIZOPHRENIA; SEGMENTATION; REDUCTION; CORTEX; ABNORMALITIES; CONNECTIVITY;
D O I
10.1176/appi.ajp.2020.19101099
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Thalamus models of psychosis implicate association nuclei in the pathogenesis of psychosis and mechanisms of cognitive impairment. Studies to date have provided conflicting findings for structural deficits specific to these nuclei. The authors sought to characterize thalamic structural abnormalities in psychosis and a neurodevelopmental cohort, and to determine whether nuclear volumes were associated with cognitive function. Methods: Thalamic nuclei volumes were tested in a cross-sectional sample of 472 adults (293 with psychosis) and the Philadelphia Neurodevelopmental Cohort (PNC), consisting of 1,393 youths (398 with psychosis spectrum symptoms and 609 with other psychopathologies), using a recently developed, validated method for segmenting thalamic nuclei and complementary voxel-based morphometry. Cognitive function was measured with the Screen for Cognitive Impairment in Psychiatry in the psychosis cohort and the Penn Computerized Neurocognitive Battery in the PNC. Results: The psychosis group had smaller pulvinar, mediodorsal, and, to a lesser extent, ventrolateral nuclei volumes compared with the healthy control group. Youths with psychosis spectrum symptoms also had smaller pulvinar volumes, compared with both typically developing youths and youths with other psychopathologies. Pulvinar volumes were positively correlated with general cognitive function. Conclusions: The study findings demonstrate that smaller thalamic association nuclei represent a neurodevelopmental abnormality associated with psychosis, risk for psychosis in youths, and cognitive impairment. Identifying specific thalamic nuclei abnormalities in psychosis has implications for early detection of psychosis risk and treatment of cognitive impairment in psychosis.
引用
收藏
页码:1159 / 1167
页数:9
相关论文
共 50 条
  • [1] Thalamic Nuclei Volumes in Psychotic Disorders and Youth With Psychosis Spectrum Symptoms
    Huang, Anna
    Rogers, Baxter
    Sheffield, Julia
    Jalbrzikowski, Maria
    Anticevic, Alan
    Blackford, Jennifer
    Heckers, Stephan
    Woodward, Neil
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S374 - S374
  • [2] Thalamic Nuclei Volumes in Psychotic Disorders and Youth With Psychosis Spectrum Symptoms
    Huang, Anna
    Rogers, Baxter
    Sheffield, Julia
    Jalbrzikowski, Maria
    Anticevic, Alan
    Blackford, Jennifer
    Heckers, Stephan
    Woodward, Neil
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S447 - S447
  • [3] Age-Associated Deviations of Amygdala Functional Connectivity in Youths With Psychosis Spectrum Disorders: Relevance to Psychotic Symptoms
    Jalbrzikowski, Maria
    Murty, Vishnu P.
    Tervo-Clemmens, Brenden
    Foran, William
    Luna, Beatriz
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (03): : 196 - 207
  • [4] Insula Structure in Psychotic Disorders and Youth With Psychosis Spectrum Symptoms
    Sheffield, Julia
    Huang, Anna
    Rogers, Baxter
    Blackford, Jennifer
    Heckers, Stephan
    Woodward, Neil
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S406 - S406
  • [5] Shared Architecture of Dimensional Psychotic Symptoms Across Psychosis Spectrum Disorders
    Perez-Rodriguez, M. Mercedes
    Ospina, Luz
    Fisher, Amanda
    Cuesta-Diaz, Armando
    Nitzburg, George
    Russo, Manuela
    Shanahan, Megan
    McNamara, Margaret
    Hazlett, Erin
    Koenigsberg, Harold
    New, Antonia
    Siever, Larry
    Burdick, Katherine
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S385 - S385
  • [6] Decreased basal ganglia and thalamic iron in early psychotic spectrum disorders are associated with increased psychotic and schizotypal symptoms
    Sui, Yu Veronica
    McKenna, Faye
    Bertisch, Hilary
    Storey, Pippa
    Anthopolos, Rebecca
    Goff, Donald C.
    Samsonov, Alexey
    Lazar, Mariana
    MOLECULAR PSYCHIATRY, 2022, 27 (12) : 5144 - 5153
  • [7] Decreased basal ganglia and thalamic iron in early psychotic spectrum disorders are associated with increased psychotic and schizotypal symptoms
    Yu Veronica Sui
    Faye McKenna
    Hilary Bertisch
    Pippa Storey
    Rebecca Anthopolos
    Donald C. Goff
    Alexey Samsonov
    Mariana Lazar
    Molecular Psychiatry, 2022, 27 : 5144 - 5153
  • [8] Thalamic nuclei volumes in schizophrenia and bipolar spectrum disorders-Associations with diagnosis and clinical characteristics
    Morch-Johnsen, Lynn
    Jorgensen, Kjetil Nordbo
    Barth, Claudia
    Nerland, Stener
    Bringslid, Ida Kippersund
    Wortinger, Laura A.
    Andreou, Dimitrios
    Melle, Ingrid
    Andreassen, Ole A.
    Agartz, Ingrid
    SCHIZOPHRENIA RESEARCH, 2023, 256 : 26 - 35
  • [9] Thalamic Nuclei Reductions Across the Psychosis Spectrum: A BSNIP Study
    Zeng, Victor
    Lizano, Paulo
    Hegde, Rachal
    Lutz, Olivia
    Hoang, Dung
    Adhan, Iniya
    Nisenson, Melanie
    Raymond, Nicolas
    Lai, Matthew
    Bannai, Deepthi
    Tamminga, Carol
    Clementz, Brett
    Pearlson, Godfrey
    Sweeney, John
    Keshavan, Matcheri
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S343 - S344
  • [10] Insula Structure in Psychotic Disorders and Psychosis Spectrum Youth
    Sheffield, Julia
    Huang, Anna
    Rogers, Baxter
    Blackford, Jennifer Urbano
    Heckers, Stephan
    Woodward, Neil
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 126 - 127